Parnell Pharmaceuticals Holdings Ltd (PARNF)

Last Closing Price: --

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Parnell Pharmaceuticals Holdings Ltd (PARNF) had Net Income of $-1.07M for the most recently reported fiscal year, ending 2021-12-31.

Figures for fiscal year ending 2021-12-31
Income Statement Financials
$27.22M
Net Income
$-1.07M
$11.19M
$16.03M
$23.02M
$4.20M
$-5.27M
$-1.07M
$-1.07M
$-1.07M
$-1.07M
$-1.07M
$-1.07M
$4.20M
$8.23M
28.96M
28.96M
$-0.04
$-0.04
Balance Sheet Financials
$8.77M
$7.29M
$21.36M
$30.13M
$8.94M
$43.95M
$47.32M
$56.26M
$-26.13M
$-37.43M
$-26.13M
29.63M
Cash Flow Statement Financials
$4.10M
$-3.13M
$0.05M
$3.03M
$3.37M
$0.34M
$0.59M
--
--
Fundamental Metrics & Ratios
0.98
--
--
2.47
-1.69
58.88%
15.43%
15.43%
30.24%
-3.92%
-3.92%
$3.43M
--
--
--
0.90
3.98
16.35
22.32
4.08%
2.85%
-3.54%
-5.99%
$-0.88
$0.12
$0.14